Home
Science & Technology
Publications

Publications:
Our Research

Filter

Filter

Research Area
Technology
Resource type
Category
216 results found
Sep 23, 2021
Publication
Novavax led
The Lancet Infectious Diseases
Seasonal influenza, Matrix-M® adjuvant
Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial
Shinde, Vivek, Cho, Iksung, Plested, Joyce S., et al.
View
Sep 21, 2021
Publication
Collaborative
Cell Reports Medicine
COVID-19, Matrix-M® adjuvant
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
Gorman, Matthew J., Patel, Nita , Guebre-Xabier, Mimi, et al.
View
Jul 14, 2021
Poster
COVID-19
Accessing Non-Peer-Reviewed Preprint Literature from Various Servers: An Essential Library Resource to Support Vaccine Development During A Global Pandemic

During the Covid-19 pandemic, new information has been changing rapidly and there is significant lag time for new manuscripts to become fully published journal articles. Please download the summary and watch the corresponding video.

Glass, Sharon
View/Download
Jun 30, 2021
Publication
Novavax led
The New England Journal of Medicine
COVID-19
Safety and Efficacy of the NVX-CoV2373 Covid-19 Vaccine
Heath, Paul T., Galiza, Eva P., Baxter, David N. , et al.
View
May 25, 2021
Presentation
COVID-19
Novavax COVID-19 Program Update for ISV

Dr. Gregory Glenn's COVID-19 presentation for the International Society for Vaccines (ISV) May 2021.

Glenn, Gregory
View/Download
May 5, 2021
Publication
Collaborative
The Lancet
Malaria, Matrix-M® adjuvant
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
Datoo, Mehreen S., Natama, Magloire H., Somé, Athanase, et al.
View
May 5, 2021
Publication
Novavax led
Pre-print
COVID-19, Seasonal influenza
Combination Respiratory Vaccine Containing Recombinant SARS-CoV-2 Spike and Quadrivalent Seasonal Influenza Hemagglutinin Nanoparticles with Matrix-M Adjuvant
Massare, Michael J., Patel, Nita, Zhou, Bin, et al.
View
May 5, 2021
Publication
Novavax led
New England Journal of Medicine
COVID-19
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Shinde, Vivek, Bhikha, Sutika, Hoosain, Zaheer, et al.
View
May 4, 2021
Clinical trial protocol
COVID-19
Current Protocol for Phase 3 Clinical Trial of NVX-CoV2373 in the U.K.
View/Download
May 4, 2021
Presentation
COVID-19
Novavax COVID-19 Program Update for World Vaccine Congress

Dr. Gregory Glenn's presentation at the World Vaccine Congress Washington 2021.

Glenn, Gregory
View/Download